Initial description of cerebral oximetry measurement in heart failure patients
Congestive Heart Failure, 05/04/2012Rifai L et al.
In this initial description of SctO2 in patients with stage C HF, authors noted a wide range of SctO2 measurements. For most patients, there was a profound SpO2-SctO2 difference, despite near–normal peripheral oxygen saturations. The authors suggest that SctO2 is a potentially important biomarker to measure in HF patients and may be a useful marker of target organ perfusion.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.